Esophageal carcinoma: Non-surgical therapy;Ösophaguskarzinom - Nicht-chirurgische therapie

Praxis

Volumn 93, Issue 49, 2004, Pages 2057-2064

  Geissler, M ^a   Schwacha, H ^a   Eggstein, S ^a   Usadel, H ^a   Harder, J ^a   Opitz, O ^a   Arnold, C ^a   Grimm, C F ^a   Blum, H E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Brachytherapy; Chemotherapy; Esophageal carcinoma; Mucosal resection; Radiation

Indexed keywords

ANTINEOPLASTIC AGENT;

BRACHYTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; HUMAN; INCIDENCE; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STENT; TIME;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; STENTS; TIME FACTORS;

EID: 9644301299     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.93.49.2057     Document Type: Review

References (24)

1. Bareiss D., Stabenow R., Muller R. et al.: Current epidemiology of carcinoma of the esophagus and cardia in Germany. Dtsch Med Wochenschr 127: 1367-1374, 2002. (Pubitemid 34680767)
2. Stein H.J., Feith M., Siewert J.R.: Cancer of the esophagogastric junction. Surg Oncol 9: 35-41, 2000.
3. Vazquez-Sequeiros E., Wang L., Burgart L. et al.: Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma. Gastroenterology 122: 1815-1821, 2002. (Pubitemid 34651426)
4. Buskens C.J., Van Rees B.P., Sivula A. et al.: Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 122: 1800-1807, 2002. (Pubitemid 34651424)
5. Weber W.A., Ott K., Becker K. et al.: Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19: 3058-3065, 2001. (Pubitemid 32565444)
6. Scheiman J.M., Wang K.K.: EMR for early stage esophageal cancer: setting the stage for improved patient outcomes. Gastrointest Endosc 58: 244-246, 2003. (Pubitemid 38220275)
7. Wolfsen H.C., Woodward T.A., Raimondo M.: Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77: 1176-1181, 2002. (Pubitemid 35266366)
8. Ohtsu A.: The latest advances in chemotherapy for gastrointestinal cancers. Int J Clin Oncol 8: 234-238. 2003.
9. Shimizu Y., Tsukagoshi H., Fujita M., Hosokawa M., Kato M., Asaka M.: Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 56: 387-390, 2002.
10. Leonard G.D., McCaffrey J.A., Maher M.: Optimal therapy for oesophageal cancer. Cancer Treat Rev 29: 275-282, 2003. (Pubitemid 37069657)
11. MRC: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727-1733, 2002. http://www.eortc.be/.
12. Nygaard K., Hagen S., Hansen H.S. et al.: Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer.World J Surg 16: 1104-1109; discussion 1110, 1992.
13. Apinop C., Puttisak P., Preecha N.: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41: 391-393, 1994. (Pubitemid 24273251)
14. Le Prise E., Etienne P.L., Meunier B. et al.: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779-1784, 1994. (Pubitemid 24101950)
15. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T.P.: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462-467, 1996. (Pubitemid 26269945)
16. Bosset J.F., Gignoux M., Triboulet J.P. et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161-167, 1997. (Pubitemid 27306287)
17. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., Strawderman M.: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305-313, 2001. (Pubitemid 32112841)
18. Burmeister B.H.: A randomised phase III trial of preoperative radiochemotherapy followed by surgery versus surgery alone for localized resectable cancer of the esophagus. Proc Am Soc Clin Oncol 21: 130a, 2002.
19. Herskovic A., Martz K., al-Sarraf M. et al.: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598, 1992.
20. Bedenne L.: Randomised phase III trial in locally advanced esophageal cancer: radiochemotherapy folowed by surgery versus radiochemotherapy alone (FFCD9102). Proc Am Soc Clin Oncol 21: 130a, 2002.
21. Bidoli P., Bajetta E., Stani S.C. et al.: Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer 94: 352-361, 2002. (Pubitemid 34081363)
22. Fink U., Ott K., Weber W., Siewert J.R.: Neoadjuvant therapeutic principles guided by response prediction and evaluation. Kongressbd Dtsch Ges Chir Kongr 119: 829-833, 2002.
23. Stahl M.: Chemotherapy of esophageal carcinoma. Onkologie 22: 98-104, 1999.
24. Allum W.H., Griffin S.M., Watson A., Colin-Jones D.: Guidelines for the management of oesophageal and gastric cancer. Gut 50 (suppl 5): v1-23, 2002.